EFMH
COGT icon

E Fund Management (HK)’s Cogent Biosciences COGT Stock Holding History

E Fund Management (HK)’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15K Buy
+389
New +$14.4K 0.01% 251

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

E Fund Management (HK)'s COGT Position: Q1 2026 in Review

E Fund Management (HK) opened a new position in Cogent Biosciences (COGT) in Q1 2026: 389 shares worth $15K. The stake represents 0.01% of the portfolio and ranks #251 among its holdings.

305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • E Fund Management (HK) held 389 shares of Cogent Biosciences worth $15K as of Q1 2026.
  • Cogent Biosciences was a new E Fund Management (HK) position in Q1 2026.
  • Cogent Biosciences made up 0.01% of E Fund Management (HK)'s portfolio in Q1 2026, its #251 holding.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on E Fund Management (HK)'s 13F filing for Q1 2026, filed 8 Apr 2026.